Benitec Biopharma annual total assets
2019
2020
2021
2022
2023
2024
2025
Benitec Biopharma Total Assets Growth & History (BNTC)
Benitec Biopharma's total assets was $99.6M for fiscal 2025.
View full Benitec Biopharma company overviewBenitec Biopharma annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | $99.6M | $47.4M | +90.75% |
| 2024 | 2024-06-30 | $52.2M | $47.7M | +1069.58% |
| 2023 | 2023-06-30 | $4.5M | −$1.5M | −25.26% |
| 2022 | 2022-06-30 | $6.0M | −$15.4M | −72.06% |
| 2021 | 2021-06-30 | $21.4M | $9.8M | +84.51% |
| 2020 | 2020-06-30 | $11.6M | −$7.6M | −39.76% |
| 2019 | 2019-06-30 | $19.2M | — | — |
Benitec Biopharma quarterly total assets
Q4.19
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-03-31 | $187.0M | $81.8M | +77.74% |
| Q2 2026 | 2025-12-31 | $190.7M | $111.6M | +141.16% |
| Q1 2026 | 2025-09-30 | $96.0M | $27.3M | +39.63% |
| Q4 2025 | 2025-06-30 | $99.6M | $47.4M | +90.75% |
| Q3 2025 | 2025-03-31 | $105.2M | $90.2M | +601.44% |
| Q2 2025 | 2024-12-31 | $79.1M | $57.7M | +270.29% |
| Q1 2025 | 2024-09-30 | $68.8M | $41.7M | +154.22% |
| Q4 2024 | 2024-06-30 | $52.2M | $47.7M | +1069.58% |
| Q3 2024 | 2024-03-31 | $15.0M | $6.8M | +82.47% |
| Q2 2024 | 2023-12-31 | $21.4M | $9.4M | +79.36% |
| Q1 2024 | 2023-09-30 | $27.1M | $8.9M | +49.34% |
| Q4 2023 | 2023-06-30 | $4.5M | −$1.5M | −25.26% |
| Q3 2023 | 2023-03-31 | $8.2M | −$1.8M | −18.32% |
| Q2 2023 | 2022-12-31 | $11.9M | −$2.1M | −15.05% |
| Q1 2023 | 2022-09-30 | $18.1M | $279,000 | +1.56% |
| Q4 2022 | 2022-06-30 | $6.0M | −$15.4M | −72.06% |
| Q3 2022 | 2022-03-31 | $10.1M | −$3.4M | −25.05% |
| Q2 2022 | 2021-12-31 | $14.0M | −$1.5M | −9.66% |
| Q1 2022 | 2021-09-30 | $17.8M | $8.9M | +100.04% |
| Q4 2021 | 2021-06-30 | $21.4M | $9.8M | +84.51% |
| Q3 2021 | 2021-03-31 | $13.4M | — | — |
| Q2 2021 | 2020-12-31 | $15.5M | — | — |
| Q1 2021 | 2020-09-30 | $8.9M | — | — |
| Q4 2020 | 2020-06-30 | $11.6M | −$7.6M | −39.76% |
| Q4 2019 | 2019-06-30 | $19.2M | — | — |
Benitec Biopharma total assets trends
Over the last five fiscal years, Benitec Biopharma's total assets increased from $11.6M to $99.6M, a change of $88.0M. The latest reported quarter, Q3 2026, shows $187.0M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Benitec Biopharma source filings ↗